KL 15 Treatment of very preterm preeclampsia via heparin-mediated extracorporeal LDL-precipitation (H.E.L.P) apheresis results in favorable fetal outcome and weight gain without lowering soluble FMS-like tyrosine kinase-1 (sFlt-1): The Freiburg preeclampsia HELP-apheresis study
Titel:
KL 15 Treatment of very preterm preeclampsia via heparin-mediated extracorporeal LDL-precipitation (H.E.L.P) apheresis results in favorable fetal outcome and weight gain without lowering soluble FMS-like tyrosine kinase-1 (sFlt-1): The Freiburg preeclampsia HELP-apheresis study
Auteur:
Winkler, Karl Contini, Christiane König, Brigitte Krumrey, Bärbel Pütz, Gerhard Zschiedrich, Stefan Pecks, Ulrich Stavropoulou, Dimitra Prömpeler, Heinrich Kunze, Mirjam Markfeld-Erol, Filiz